Kolexia
Vainchenker William Médecine générale
Vainchenker William
Médecine générale
Gustave-Roussy
Villejuif, France
254 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndromes myéloprolifératifs Myélofibrose primitive Leucémies Thrombopénie Leucémie aigüe myéloïde Thrombocytémie essentielle Thrombocytose Tumeurs hématologiques Polyglobulie primitive essentielle

Collaborateurs

Voir plus
Solary Eric
Solary Eric
Gustave-Roussy, Villejuif, France
Kiladjian Jean-Jacques
Kiladjian Jean-Jacques
Hôpital Saint-Louis, Paris, France
Pasquier Florence
Pasquier Florence
Gustave-Roussy, Villejuif, France
Cassinat Bruno
Cassinat Bruno
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
Sanofi
2 collaboration(s)
Dernière en 2021
Abbvie
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Deregulation of the p19/CDK4/CDK6 axis in Jak2 megakaryocytes accelerates the development of myelofibrosis.
Leukemia   20 février 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
American journal of hematology   26 janvier 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
Single Cell Analysis and Functional Features of Circulating CD34 + Cells from Patients with Sickle Cell Anaemia Unveil a Defect in the Myeloid Lineage
65th ASH Annual Meeting Abstracts   02 novembre 2023
An Atypical Somatic Calr Variant Acquired in Cis to a Germline Calr variant Induces Constitutive Signaling of the Thrombopoietin Receptor and Results in Essential Thrombocythemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Recent advances in therapies for primary myelofibrosis.
Faculty reviews   26 septembre 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
Nature genetics   04 septembre 2023
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.
Haematologica   01 août 2023
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
Leukemia   26 avril 2023